Analyst firms · Morgan Stanley · ALL

Morgan Stanley ALL price target and rating history

Allstate Corporation (ALL) · Finance

Morgan Stanley rates Allstate Corporation (ALL) Equal-Weight with a $215 price target, as of its latest action on Dec 16, 2025. It has published 7 rating actions on ALL since August 2021, including 1 upgrade and 1 downgrade. Across 8 firms with a ALL price target in the last 12 months, the median target is $238. Morgan Stanley's $215 is 10% below that.

Current rating
Equal-Weight
Price target
$215
Median target, all firms
$238
Actions on ALL
7

Morgan Stanley price target on ALL

$215$166$11720222023202420252026
Morgan Stanley price target on ALL, each point a stated target, August 2021 to December 2025.

Every Morgan Stanley rating on ALL

How other firms rate ALL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
HSBCHold$271Nov 6, 2026
Wells FargoEqual Weight$236Oct 12, 2026
Argus ResearchHoldAug 28, 2026
Keefe, Bruyette & WoodsUnderperform$250Aug 20, 2026
CitigroupSell$240Aug 11, 2026
UBSNeutral$261Jul 15, 2026
Goldman SachsNeutral$231Mar 5, 2026
TD CowenHold$231Jan 12, 2026
William BlairMkt PerformDec 18, 2025
Morgan StanleyEqual-Weight$215Dec 16, 2025

Questions about Morgan Stanley and ALL

What is Morgan Stanley's price target for ALL?
Morgan Stanley's latest stated price target for Allstate Corporation (ALL) is $215, from its action on Dec 16, 2025.
What is Morgan Stanley's rating on ALL?
Morgan Stanley rates ALL Equal-Weight, a neutral rating, as of Dec 16, 2025.
When did Morgan Stanley last change its view on ALL?
On Dec 16, 2025, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $215.
How does Morgan Stanley's ALL target compare with other analysts?
Across 8 firms with a ALL price target in the last 12 months, the median target is $238. Morgan Stanley's $215 is 10% below that.

More ALL rating histories

All Morgan Stanley ratingsALL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.